Provectus Biopharmaceuticals Inc.’ Data On PV-10 To Be Presented At Hemonc Today Melanoma And Cutaneous Malignancies Annual Meeting

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT,, a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that Dr. Sanjiv Agarwala will present data on PV-10, the Company’s novel investigational drug for cancer, at the HemOnc Today Melanoma and Cutaneous Malignancies Annual Meeting on Friday, April 10, 2015 at the Sheraton New York Times Square Hotel.

Help employers find you! Check out all the jobs and post your resume.

Back to news